Literature DB >> 26434817

Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.

Xia Liu1, Fen Yun, Lin Shi, Zhe-Hai Li, Nian-Rong Luo, Yong-Feng Jia.   

Abstract

The epithelial-mesenchymal transition (EMT) is a cellular process though which an epithelial phenotype can be converted into a phenotype of mesenchymal cells. Under physiological conditions EMT is important for embryogenesis, organ development, wound repair and tissue remodeling. However, EMT may also be activated under pathologic conditions, especially in carcinogenesis and metastatic progression. Major signaling pathways involved in EMT include transforming growth factor β(TGF-β), Wnt, Notch, Hedgehog and other signaling pathways. These pathways are related to several transcription factors, including Twist, Smads and zinc finger proteins snail and slug. These interact with each other to provide crosstalk between the relevant signaling pathways. This review lays emphasis on studying the relationship between EMT and signaling pathways in carcinogenesis and metastatic progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26434817     DOI: 10.7314/apjcp.2015.16.15.6201

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  34 in total

1.  Hedgehog pathway plays a vital role in HIV-induced epithelial-mesenchymal transition of podocyte.

Authors:  Xiqian Lan; Hongxiu Wen; Kang Cheng; Andrei Plagov; Seyedeh Shadafarin Marashi Shoshtari; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2017-01-31       Impact factor: 3.905

2.  Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.

Authors:  Lulu Mao; Whitney Summers; Shulin Xiang; Lin Yuan; Robert T Dauchy; Amberly Reynolds; Melissa A Wren-Dail; David Pointer; Tripp Frasch; David E Blask; Steven M Hill
Journal:  Mol Cancer Res       Date:  2016-08-17       Impact factor: 5.852

3.  Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.

Authors:  Rui Ma; Jiang Chen; Shaojie Jiang; Shuang Lin; Xiuming Zhang; Xiao Liang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Clinical applications of mouse models for breast cancer engaging HER2/neu.

Authors:  Elizabeth A Fry; Pankaj Taneja; Kazushi Inoue
Journal:  Integr Cancer Sci Ther       Date:  2016-10-28

5.  Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition.

Authors:  Jinrong He; Shanshan Chen; Tong Yu; Weiqun Chen; Jin Huang; Caixia Peng; Yu Ding
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 6.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 7.  Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.

Authors:  Nima Hemmat; Ahad Mokhtarzadeh; Mohammad Aghazadeh; Farhad Jadidi-Niaragh; Behzad Baradaran; Hossein Bannazadeh Baghi
Journal:  Mol Biol Rep       Date:  2020-05-07       Impact factor: 2.742

8.  Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles.

Authors:  Giulia Chiabotto; Stefania Bruno; Federica Collino; Giovanni Camussi
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

9.  Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.

Authors:  Yang Chong; Dong Tang; Qingquan Xiong; Xuetong Jiang; Chuanqi Xu; Yuqin Huang; Jie Wang; Huaicheng Zhou; Youquan Shi; Xiaoqing Wu; Daorong Wang
Journal:  J Exp Clin Cancer Res       Date:  2016-11-11

10.  Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition.

Authors:  Yin-Kai Chao; Ta-Lun Peng; Wen-Yu Chuang; Chi-Ju Yeh; Yan-Liang Li; Ya-Ching Lu; Ann-Joy Cheng
Journal:  J Cancer       Date:  2016-08-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.